20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Beam Therapeutics (NASDAQ:BEAM) reported its Q4 earnings results on Tuesday, February 27, 2024 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Beam Therapeutics beat estimated earnings by 271.0%, reporting an EPS of $1.73 versus an estimate of $-1.01.
Revenue was up $296.15 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.12 which was followed by a 3.0% drop in the share price the next day.
Here's a look at Beam Therapeutics's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -1.34 | -1.42 | -1.34 | -1.33 |
EPS Actual | -1.22 | -1.08 | -1.33 | -0.54 |
Revenue Estimate | 17.49M | 18.05M | 14.08M | 12.53M |
Revenue Actual | 17.19M | 20.12M | 24.21M | 20.04M |
To track all earnings releases for Beam Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!